Table 1.
Baseline demographics of the studied patients
| All patients (N = 6) | |
|---|---|
| Age (years) | 61.7 ± 10.3 |
| Gender (male) | 5 (83.3%) |
| Current smoker | 0 (0%) |
| Family history of CAD | 4 (66.7%) |
| Co-morbidities | |
| Diabetes mellitus | 3 (50.0%) |
| Hypertension | 4 (66.7) |
| Hypercholesterolemia | 4 (66.7) |
| Renal failure* | 0 (0%) |
| Anemia | 0 (0%) |
| Previous PCI | 2 (33.3%) |
| LV function** | |
| Normal LV function | 5 (83.3%) |
| Impaired LV function | 1 (16.7%) |
| Studied vessels | (n = 20) |
| Left anterior descending artery | 6 (30.0%) |
| Number of frames | 32,171 |
| Number of end-diastolic frames | 1219 |
| Left circumflex artery | 9 (45.0%) |
| Number of frames | 31,306 |
| Number of end-diastolic frames | 1070 |
| Right coronary artery | 5 (25.0%) |
| Number of frames | 29,049 |
| Number of end-diastolic frames | 1008 |
| Medications at discharge | |
| Aspirin | 6 (100.0%) |
| Thienopyridines | 6 (100.0%) |
| Beta-blocker | 2 (33.3%) |
| Statin | 6 (100.0%) |
CAD coronary artery disease, LV left ventricle, PCI percutaneous coronary intervention
*Renal failure was defined as an estimated glomerular filtration rate of < 60 ml/min/1.73 m2
**Normal LV function was defined as LV ejection fraction ≥ 50%; impaired LV function was defined as LV ejection fraction > 30% and < 50%